Logo image of EMBC

EMBECTA CORP (EMBC) Stock Fundamental Analysis

USA - NASDAQ:EMBC - US29082K1051 - Common Stock

14.48 USD
-0.07 (-0.48%)
Last: 11/17/2025, 11:12:49 AM
Fundamental Rating

6

EMBC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. EMBC has an average financial health and profitability rating. A decent growth rate in combination with a cheap valuation! Better keep an eye on EMBC. These ratings would make EMBC suitable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

EMBC had positive earnings in the past year.
EMBC had a positive operating cash flow in the past year.
Each year in the past 5 years EMBC has been profitable.
EMBC had a positive operating cash flow in each of the past 5 years.
EMBC Yearly Net Income VS EBIT VS OCF VS FCFEMBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

With an excellent Return On Assets value of 7.22%, EMBC belongs to the best of the industry, outperforming 88.30% of the companies in the same industry.
EMBC's Return On Invested Capital of 23.87% is amongst the best of the industry. EMBC outperforms 98.94% of its industry peers.
EMBC had an Average Return On Invested Capital over the past 3 years of 24.33%. This is significantly above the industry average of 8.98%.
Industry RankSector Rank
ROA 7.22%
ROE N/A
ROIC 23.87%
ROA(3y)10.82%
ROA(5y)28.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)24.33%
ROIC(5y)35.9%
EMBC Yearly ROA, ROE, ROICEMBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

EMBC has a better Profit Margin (7.58%) than 77.66% of its industry peers.
EMBC's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 28.66%, EMBC belongs to the top of the industry, outperforming 96.81% of the companies in the same industry.
EMBC's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 63.95%, EMBC is in the better half of the industry, outperforming 66.49% of the companies in the same industry.
In the last couple of years the Gross Margin of EMBC has declined.
Industry RankSector Rank
OM 28.66%
PM (TTM) 7.58%
GM 63.95%
OM growth 3Y-15.62%
OM growth 5Y-10.93%
PM growth 3Y-41.94%
PM growth 5Y-29.11%
GM growth 3Y-1.58%
GM growth 5Y-1.58%
EMBC Yearly Profit, Operating, Gross MarginsEMBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EMBC is creating value.
The number of shares outstanding for EMBC has been increased compared to 1 year ago.
Compared to 5 years ago, EMBC has more shares outstanding
EMBC has a better debt/assets ratio than last year.
EMBC Yearly Shares OutstandingEMBC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EMBC Yearly Total Debt VS Total AssetsEMBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.00 indicates that EMBC is not a great score, but indicates only limited risk for bankruptcy at the moment.
EMBC has a Altman-Z score of 2.00. This is in the better half of the industry: EMBC outperforms 61.70% of its industry peers.
EMBC has a debt to FCF ratio of 11.34. This is a negative value and a sign of low solvency as EMBC would need 11.34 years to pay back of all of its debts.
EMBC has a Debt to FCF ratio of 11.34. This is in the better half of the industry: EMBC outperforms 71.28% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 11.34
Altman-Z 2
ROIC/WACC3.86
WACC6.19%
EMBC Yearly LT Debt VS Equity VS FCFEMBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

EMBC has a Current Ratio of 2.47. This indicates that EMBC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.47, EMBC is in line with its industry, outperforming 48.94% of the companies in the same industry.
A Quick Ratio of 1.78 indicates that EMBC should not have too much problems paying its short term obligations.
The Quick ratio of EMBC (1.78) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 1.78
EMBC Yearly Current Assets VS Current LiabilitesEMBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

EMBC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.88%, which is quite good.
The earnings per share for EMBC have been decreasing by -29.06% on average. This is quite bad
Looking at the last year, EMBC shows a decrease in Revenue. The Revenue has decreased by -1.47% in the last year.
Measured over the past years, EMBC shows a small growth in Revenue. The Revenue has been growing by 0.25% on average per year.
EPS 1Y (TTM)11.88%
EPS 3Y-42.79%
EPS 5Y-29.06%
EPS Q2Q%51.35%
Revenue 1Y (TTM)-1.47%
Revenue growth 3Y-1.21%
Revenue growth 5Y0.25%
Sales Q2Q%8.44%

3.2 Future

EMBC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.85% yearly.
EMBC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.68% yearly.
EPS Next Y19.34%
EPS Next 2Y10.44%
EPS Next 3Y7.82%
EPS Next 5Y5.85%
Revenue Next Year-2.9%
Revenue Next 2Y-1.46%
Revenue Next 3Y-0.8%
Revenue Next 5Y0.68%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EMBC Yearly Revenue VS EstimatesEMBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EMBC Yearly EPS VS EstimatesEMBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

9

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 4.96, which indicates a rather cheap valuation of EMBC.
Compared to the rest of the industry, the Price/Earnings ratio of EMBC indicates a rather cheap valuation: EMBC is cheaper than 97.34% of the companies listed in the same industry.
EMBC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.89.
The Price/Forward Earnings ratio is 4.81, which indicates a rather cheap valuation of EMBC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EMBC indicates a rather cheap valuation: EMBC is cheaper than 99.47% of the companies listed in the same industry.
EMBC is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.96
Fwd PE 4.81
EMBC Price Earnings VS Forward Price EarningsEMBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EMBC is valued cheaper than 97.34% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EMBC is valued cheaper than 98.40% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.4
EV/EBITDA 6.01
EMBC Per share dataEMBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

EMBC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EMBC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y10.44%
EPS Next 3Y7.82%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.16%, EMBC is a good candidate for dividend investing.
EMBC's Dividend Yield is rather good when compared to the industry average which is at 1.69. EMBC pays more dividend than 99.47% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, EMBC pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.16%

5.2 History

EMBC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EMBC Yearly Dividends per shareEMBC Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

EMBC pays out 41.75% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP41.75%
EPS Next 2Y10.44%
EPS Next 3Y7.82%
EMBC Yearly Income VS Free CF VS DividendEMBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
EMBC Dividend Payout.EMBC Dividend Payout, showing the Payout Ratio.EMBC Dividend Payout.PayoutRetained Earnings

EMBECTA CORP

NASDAQ:EMBC (11/17/2025, 11:12:49 AM)

14.48

-0.07 (-0.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-25 2025-11-25/bmo
Inst Owners101.84%
Inst Owner Change-1.94%
Ins Owners0.46%
Ins Owner Change0.68%
Market Cap846.94M
Revenue(TTM)1.10B
Net Income(TTM)83.60M
Analysts51.11
Price Target17 (17.4%)
Short Float %4.83%
Short Ratio6.54
Dividend
Industry RankSector Rank
Dividend Yield 4.16%
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DP41.75%
Div Incr Years0
Div Non Decr Years2
Ex-Date08-29 2025-08-29 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.83%
Min EPS beat(2)29.98%
Max EPS beat(2)41.68%
EPS beat(4)4
Avg EPS beat(4)34.39%
Min EPS beat(4)21.87%
Max EPS beat(4)44.01%
EPS beat(8)8
Avg EPS beat(8)41.88%
EPS beat(12)10
Avg EPS beat(12)32.96%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.06%
Min Revenue beat(2)-0.01%
Max Revenue beat(2)4.13%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-0.01%
Max Revenue beat(4)4.13%
Revenue beat(8)6
Avg Revenue beat(8)2.11%
Revenue beat(12)10
Avg Revenue beat(12)2.35%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.29%
EPS NY rev (1m)0%
EPS NY rev (3m)2.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 4.96
Fwd PE 4.81
P/S 0.77
P/FCF 6.4
P/OCF 6.31
P/B N/A
P/tB N/A
EV/EBITDA 6.01
EPS(TTM)2.92
EY20.17%
EPS(NY)3.01
Fwd EY20.8%
FCF(TTM)2.26
FCFY15.62%
OCF(TTM)2.3
OCFY15.86%
SpS18.85
BVpS-11.45
TBVpS-11.84
PEG (NY)0.26
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 7.22%
ROE N/A
ROCE 35.84%
ROIC 23.87%
ROICexc 32.32%
ROICexgc 33.49%
OM 28.66%
PM (TTM) 7.58%
GM 63.95%
FCFM 12%
ROA(3y)10.82%
ROA(5y)28.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)24.33%
ROIC(5y)35.9%
ROICexc(3y)39.2%
ROICexc(5y)44.82%
ROICexgc(3y)41.18%
ROICexgc(5y)47.17%
ROCE(3y)36.53%
ROCE(5y)53.9%
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y-11.68%
ROICexc growth 3Y-17.5%
ROICexc growth 5Y-11.4%
OM growth 3Y-15.62%
OM growth 5Y-10.93%
PM growth 3Y-41.94%
PM growth 5Y-29.11%
GM growth 3Y-1.58%
GM growth 5Y-1.58%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 11.34
Debt/EBITDA 4.21
Cap/Depr 5.39%
Cap/Sales 0.18%
Interest Coverage 250
Cash Conversion 38.03%
Profit Quality 158.25%
Current Ratio 2.47
Quick Ratio 1.78
Altman-Z 2
F-Score6
WACC6.19%
ROIC/WACC3.86
Cap/Depr(3y)66.88%
Cap/Depr(5y)82.76%
Cap/Sales(3y)1.97%
Cap/Sales(5y)2.62%
Profit Quality(3y)85.85%
Profit Quality(5y)92.96%
High Growth Momentum
Growth
EPS 1Y (TTM)11.88%
EPS 3Y-42.79%
EPS 5Y-29.06%
EPS Q2Q%51.35%
EPS Next Y19.34%
EPS Next 2Y10.44%
EPS Next 3Y7.82%
EPS Next 5Y5.85%
Revenue 1Y (TTM)-1.47%
Revenue growth 3Y-1.21%
Revenue growth 5Y0.25%
Sales Q2Q%8.44%
Revenue Next Year-2.9%
Revenue Next 2Y-1.46%
Revenue Next 3Y-0.8%
Revenue Next 5Y0.68%
EBIT growth 1Y38.48%
EBIT growth 3Y-16.64%
EBIT growth 5Y-10.7%
EBIT Next Year38.7%
EBIT Next 3Y10.75%
EBIT Next 5Y8.14%
FCF growth 1Y88.46%
FCF growth 3Y-63.73%
FCF growth 5Y-46.06%
OCF growth 1Y39.75%
OCF growth 3Y-57.22%
OCF growth 5Y-41.13%

EMBECTA CORP / EMBC FAQ

What is the fundamental rating for EMBC stock?

ChartMill assigns a fundamental rating of 6 / 10 to EMBC.


Can you provide the valuation status for EMBECTA CORP?

ChartMill assigns a valuation rating of 9 / 10 to EMBECTA CORP (EMBC). This can be considered as Undervalued.


What is the profitability of EMBC stock?

EMBECTA CORP (EMBC) has a profitability rating of 6 / 10.


What is the valuation of EMBECTA CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EMBECTA CORP (EMBC) is 4.96 and the Price/Book (PB) ratio is -1.26.


Can you provide the dividend sustainability for EMBC stock?

The dividend rating of EMBECTA CORP (EMBC) is 5 / 10 and the dividend payout ratio is 41.75%.